Because challenge models to infect peripheral lymph nodes (PLNs) with Salmonella have not been reported, we performed a series of experiments to develop and refine challenge models to evaluate an intervention applied at the animal level and to provide initial estimates of efficacy of an intervention (i.e., a vaccine) to aid in the design of future studies. In each of four experiments, steers (control or vaccinated) were inoculated with Salmonella strains Montevideo or Newport, and in experiment IV, Salmonella Senftenberg was also used. Calves were euthanized 14 to 42 days postinoculation, and PLNs were collected. In the first experiment, calves were challenged with ,10
Recent research suggests that Salmonella may be commonly harbored in peripheral lymph nodes (PLNs) of cattle presented for harvest (1, 7, 10) . Because PLNs are frequently included in ground beef, Salmonella carriage in PLNs likely results in some degree of Salmonella contamination of ground beef. It may be practical to remove large, easily accessible PLNs during harvest; however, it is impractical to remove all PLNs, as cattle have many small PLNs throughout their carcasses. It is possible that preharvest control of Salmonella may complement within-plant control efforts and reduce the likelihood of ground beef contamination.
A vaccine containing siderophore receptors and porin proteins from Salmonella Newport was associated with reduced shedding of Salmonella in the feces of dairy cattle (6, 11) . In another study (9) of this vaccine, no difference in fecal Salmonella prevalence was observed, although the Salmonella prevalence and study design did not lend itself to such a comparison. No differences were observed in fecal shedding of Salmonella in studies of feedlot cattle (2) or dairy cows (8) . It is possible, however, that immunity against Salmonella may reduce the duration of infection within lymph nodes regardless of an effect, or lack thereof, within the lumen of the intestine. If so, this vaccine may reduce the prevalence of Salmonella within the PLNs of cattle presented for harvest.
Because challenge models to infect PLNs with Salmonella have not been reported, we performed a series of four experiments to develop and refine challenge models that can be used to evaluate an intervention applied at the animal level and to provide initial estimates of efficacy of an intervention (i.e., a vaccine) that can be used by researchers to aid the design of future studies.
MATERIALS AND METHODS
Care, use, and handling of experimental animals were preapproved by the Animal Care and Use Committee of the Food and Feed Safety Research Laboratory, U.S. Department of Agriculture. Recently weaned Holstein and Holstein-cross steers were purchased from a single supplier and transported to our laboratory in College Station, TX. Upon arrival, steers were weighed, identified with an ear tag, and maintained in a large outside lot and fed a commercial nonmedicated calf starter and grass hay. In experiment I, symptoms of bovine respiratory disease were observed in most steers, and all were administered enrofloxacin (Baytril 100, Bayer Animal Health LLC, Shawnee Mission, KS). In subsequent experiments, steers were metaphylactically administered tulathromycin (Draxxin, Pfizer Animal Health, New York, NY) per manufacturer's recommendations upon arrival. Rectal swabs were collected weekly prechallenge and were cultured for Salmonella.
Following acclimation (3 to 5 weeks), steers were randomly assigned to treatment (control or vaccine). Vaccinated steers were administered a commercially available Salmonella vaccine on days 0 and 21 per label directions (2 ml subcutaneous; Salmonella Newport Bacterial Extract vaccine with SRP Technology, Pfizer Animal Health, Madison, NJ), whereas control animals received a sham injection of corn oil (2 ml subcutaneous). Steers were housed outdoors in covered, concrete floored pens, either two or four steers per pen, and were fed a diet to meet or exceed their nutritional requirements. Pens were washed daily. Steers were euthanized (Euthasol, Delmarva Laboratories, Midlothian, VA), and the right and left subiliacs, popliteals, and superficial cervical nodes were collected, weighed, and cultured for the challenge strains of Salmonella as described below.
Experiment I. Thirty-two steers (average body weight 81 kg) were inoculated with either Salmonella Montevideo or Salmonella Newport in a 2 | 2 factorial design such that there were eight calves per treatment. Calves were challenged orally with 20 ml of tryptic soy broth (TSB) containing 1.0 and 1.2 | 10 10 CFU of Salmonella Montevideo or Salmonella Newport, respectively. Body weights were collected weekly throughout the experimental period. Fourteen days postchallenge, one-half of the calves in each pen (and treatment) were euthanized and PLNs were collected. At 21 days postchallenge, all remaining calves were euthanized and PLNs were collected.
Experiment II. The design was similar to that of experiment I, except that the oral challenge included 4.2 and 6.0 | 10 7 CFU of Salmonella Montevideo and Salmonella Newport, respectively. Two calves per treatment were necropsied 14 and 28 days postchallenge. Due to the poor recovery of Salmonella from the PLNs, the study was terminated.
Experiment III. Using a design similar to that of experiments I and II, calves were challenged with 1.5 and 1.3 | 10 10 CFU of Salmonella Montevideo and Salmonella Newport, respectively, in 20 ml of TSB, and two calves per treatment were necropsied on days 14, 28, 35, and 42 postchallenge. In addition to the nodes described above, axillary lymph nodes (right and left) were collected.
Experiment IV. Sixteen steers (average body weight 193 kg; two per pen by treatment) were randomly allocated to vaccine or control treatment. Calves were challenged with either Salmonella Newport (7.9 | 10 8 /ml; eight steers) or Salmonella Montevideo (1.2 | 10 9 /ml; eight steers) using a 10-lancet allergy testing instrument (ComforTen Multiple Skin Test Device, Hollister-Stier Allergy, Spokane, WA) as described elsewhere (5). Four applications of this 10-lancet instrument were made to each leg; two applications were medial and two were lateral to the metacarpus-metatarsus, such that Salmonella Newport was challenged in the right legs and Salmonella Montevideo in the left legs. Additionally, all calves were challenged on the lower abdomen with Salmonella Senftenberg (4.3 | 10 8 /ml) via two applications each on the right and left sides. A new instrument was used for the different serovars and for each calf. Three and 6 days following Salmonella challenge, one-half of the calves in each treatment were euthanized and PLNs were collected.
Lymph node processing. Within 15 min of collection, lymph nodes were transferred to the laboratory and each node was trimmed of excess fat and fascia. Trimmed lymph nodes were weighed and then surface sterilized by immersion in boiling water for 3 s. The sterilized lymph node was placed into a filtered stomacher bag, and the tissue was pulverized using a rubber mallet. Tetrathionate broth (20 ml) was added to each sample bag, followed by mixing for 60 s with a laboratory blender. For quantitative culture, 1 ml of the pulverized lymph nodetetrathionate broth mixture was removed and 50 ml was direct plated on xylose lysine deoxycholate agar using a commercially available spiral plater (Spiral Biotech Autoplate 4000, Advanced Instruments, Inc., Norwood, MA). Plates were incubated (37uC, 24 h) followed by an additional 24 h at room temperature. Black colonies were counted and converted to log CFU per gram PLN. Following spiral plating, an additional 80 ml of tetrathionate broth was added, and the lymph node-tetrathionate mixture was incubated overnight (37uC). A sample (100 ml) of this enrichment was transferred to 5 ml of Rappaport-Vassiliadis broth and incubated at 42uC for 24 h, and then it was plated for isolation on brilliant green agar supplemented with novobiocin (25 mg/ml).
Plates were incubated at 37uC overnight, and Salmonella isolates were serogrouped (three isolates per PLN). Serogrouping was conducted using slide agglutination with Salmonella antiserum (Difco, BD, Detroit, MI). Rectal swabs were enriched in 20 ml of tetrathionate broth and were incubated at 37uC overnight; next, 100 ml was inoculated into 5 ml of Rappaport-Vassiliadis broth, incubated as above, and then plated for isolation on brilliant green agar supplemented with novobiocin and incubated as described.
Statistical analysis. Data were analyzed using SAS software (version 9.3, SAS Institute Inc., Cary, NC). Contingency tables were developed and within-table dependency was evaluated using either a chi-square statistic or a Fisher's exact test. Logistic regression models were constructed to compare treatment effects.
RESULTS
Rectal swabs collected prechallenge were all Salmonella negative except for experiment III, in which a few swabs were positive and all of the isolates belonged to serogroups different from the challenge strains. In experiment I, Salmonella was recovered from 58.3 and 87.5% of PLNs and calves, respectively. No significant differences were observed in the percentage of PLNs positive for Salmonella Montevideo or Salmonella Newport on day 14 (Table 1) . At 21 days postinoculation, Salmonella Newport was recovered from fewer (P , 0.05) PLNs among the vaccinated calves (4%) compared with the control calves (54%). With two exceptions, all recovered isolate serogroups matched the respective challenge strains. Two steers in the Montevideo (serogroup C 1 ) treatment (one each control and vaccine) also had serogroup C 2 isolates cultured from their lymph nodes.
In experiment II, Salmonella was only recovered from two PLNs harvested during the first two necropsies (14 and 28 days postinoculation); therefore, the study was terminated. The higher challenge dose (i.e., ,10 10 ) in experiment III resulted in the recovery of Salmonella from PLNs. Salmonella was recovered from 35.2 and 62.5% of PLNs and calves, respectively. No significant treatment differences were observed, with one exception: the vaccine treatment decreased (P , 0.05) the percentage of Salmonella-positive left axillary nodes compared with controls across serotypes. Salmonella was recovered from fewer PLNs of calves challenged with Salmonella Newport than from those challenged with Salmonella Montevideo (Table 2 ). The majority of isolates (98%) matched the serogroup of the challenge strain. The only exceptions were that Salmonella Montevideo was cultured from the popliteal and subiliac in one calf on day 35 and from the subiliac in another calf on day 42; both of these calves were inoculated with Salmonella Newport.
In the transdermal challenge model (experiment IV), Salmonella was recovered from 58.3 and 93.8% of PLNs and calves, respectively. No treatment differences were observed among calves inoculated with Salmonella Montevideo, except that there was reduced (P , 0.05) likelihood of recovery from the right subiliac lymph nodes among vaccinates compared with controls (Table 3) . Across all nodes, the likelihood of recovery of Salmonella Newport from PLNs was lower (P~0.03) among vaccinated calves (33.3%) compared with controls (66.7%). All but one isolate matched the serogroup of regional challenge. The only exception was that one isolate from a subiliac lymph node was serogroup C 2 (presumably Newport) instead of E 4 (i.e., Senftenberg).
DISCUSSION
In the work described herein, we developed two distinct routes of Salmonella challenge that resulted in Salmonella recovery from PLNs. Because prevalence of Salmonella in PLNs is a function of incidence (i.e., rate of new PLN infections) and duration of infection, we included various windows of harvest to capture a change in the duration of infection, given that we attempted to control the incidence (i.e., by providing the challenge at one time point). In experiment I, the oral challenge, no evidence of a reduction in prevalence was observed 14 days after challenge. After 21 days, a decrease was observed in calves challenged with Salmonella Newport, which likely indicated an increased rate of clearance (or reduced duration of infection). Also, a treatment effect was observed in experiment IV (transdermal), TABLE and a numerical reduction was observed in experiment III. Despite this evidence supporting its efficacy against Salmonella Newport, no association (even with a liberal interpretation of P values) was observed for Salmonella Montevideo. This may be because there is a lack of antigenic homology between the challenge serotypes or because Montevideo has additional mechanisms for iron acquisition, or it may be due to other variations among host-bacteria interactions. It is clear from the work described herein that a substantial oral dose (i.e., ,10
10
) of Salmonella is required to result in recovery of Salmonella from PLNs. In experiment II, the lower dose failed to produce Salmonella in PLNs at detectable concentrations. On occasion, we did recover serogroups other than the challenge serogroup. It may be that repeated lower doses would have been equally effective as (or even more effective than) a single large challenge. Whereas repeated exposures may better mimic real-world events, we attempted to control incidence to the extent possible so that observed differences in vaccine status (or in serotype status) were primarily a reflection of changes in duration of infection. Once duration of infection is known for specific serotypes, variation in challenge regimens might be explored.
The recovery of serogroup C 2 in calves challenged with Salmonella Montevideo (i.e., C 1 ) (experiment I) and of C 1 in calves challenged with Salmonella Newport (experiment III) may have resulted from cross-contamination via workers, flies, birds, air movement, or the environment. Alternatively, we cannot rule out prior exposure, as these serotypes are frequently isolated from dairy cattle (3, 4, 12). As described elsewhere (5), we hypothesize that a transdermal route of infection accounts for some Salmonella recovered from the PLNs of cattle presented for harvest. Consequently, herein we report an initial extension of a transdermal route of infection (5) as the experiment IV challenge study. Multiple serotypes were used within the sample animal (i.e., Senftenberg and Montevideo or Senftenberg and Newport), and this route of challenge predictably resulted in positive PLNs. Moreover, the serogroups recovered from the PLNs that drain the challenge region (e.g., right foreleg to prescapular lymph node versus ventral abdomen to subiliac lymph node) matched in all but one instance. Similar to experiment I, a vaccine effect was observed for Salmonella Newport but not for Salmonella Montevideo.
Across all necropsy days, the relative magnitude of association between vaccine status and Salmonella Newport prevalence for experiments I, III, and IV was 20.3, 39.4, and 50%, respectively. These data, in conjunction with the control prevalence, should inform the design and sample size calculations of future studies. While the ideal window in which to sample PLNs subsequent to challenge is not completely certain, the time periods described herein provide a reasonable estimate. 
